Cao, L., Hu, S., Bai, Z., & Wu, S. (2025). Frontline therapy combining with intrathecal dexamethasone effectively alleviate immune effector cell-associated neurotoxicity syndrome in pediatric relapsed B-ALL receiving pCAR-19B. Elsevier.
Chicago Style (17th ed.) CitationCao, Lu, Shaoyan Hu, Zhengjiang Bai, and Shuiyan Wu. Frontline Therapy Combining with Intrathecal Dexamethasone Effectively Alleviate Immune Effector Cell-associated Neurotoxicity Syndrome in Pediatric Relapsed B-ALL Receiving PCAR-19B. Elsevier, 2025.
MLA (9th ed.) CitationCao, Lu, et al. Frontline Therapy Combining with Intrathecal Dexamethasone Effectively Alleviate Immune Effector Cell-associated Neurotoxicity Syndrome in Pediatric Relapsed B-ALL Receiving PCAR-19B. Elsevier, 2025.
Warning: These citations may not always be 100% accurate.